New hope for myeloma: phase 3 trial of linvoseltamab combo launches
NCT ID NCT07222761
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 27 times
Summary
This study tests a new drug, linvoseltamab, given alone or with another drug (carfilzomib) against standard treatments for people with multiple myeloma that has returned or stopped responding to prior therapy. About 915 adults who have had 1 to 3 prior treatments will take part. The goal is to see if these new options lead to deeper, longer-lasting responses and better survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aberdeen Royal Infirmary
RECRUITINGAberdeen, Aberdeenshire, AB25 2ZN, United Kingdom
-
Chonnam National University Hwasun Hospital
RECRUITINGHwasun, Jeollanam-do, 58128, South Korea
-
Gold Coast Hospital and Health Service
RECRUITINGSouthport, Queensland, 4215, Australia
-
Mater Misericordiae Ltd
RECRUITINGBrisbane, Queensland, 4101, Australia
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10021, United States
-
Ninewells Hospital and Medical School
RECRUITINGDundee, DD1 9SY, United Kingdom
-
Norfolk and Norwich University Hospital National Health Service (NHS) Foundation Trust
RECRUITINGNorwich, Norfolk, NR4 7UY, United Kingdom
-
OhioHealth
RECRUITINGColumbus, Ohio, 43214, United States
-
Royal Cornwall Hospital National Health Service (NHS) Foundation Trust
RECRUITINGTruro, Cornwall, TR1 3LJ, United Kingdom
-
Samsung Medical Center
RECRUITINGSeoul, 06351, South Korea
-
Seoul National University Hospital
RECRUITINGSeoul, 03080, South Korea
-
Seoul St. Mary's Hospital, The Catholic University of Korea
RECRUITINGSeoul, 06591, South Korea
-
Severance Hospital; Division of Hematology
RECRUITINGSeoul, 03722, South Korea
-
Ulsan University Hospital
RECRUITINGUlsan, 44033, South Korea
-
University Hospitals Birmingham NHS Trust, Center for Clinical
RECRUITINGBirmingham, West Midlands, B15 2GW, United Kingdom
-
University Hospitals Plymouth National Health Service (NHS) Foundation Trust - Hematology
RECRUITINGPlymouth, Devon, PL6 8DH, United Kingdom
Conditions
Explore the condition pages connected to this study.